Harbor Capital Advisors Inc. Has $11.79 Million Stake in SI-BONE, Inc. (NASDAQ:SIBN)

Harbor Capital Advisors Inc. increased its stake in SI-BONE, Inc. (NASDAQ:SIBN) by 35.5% in the 4th quarter, Holdings Channel reports. The firm owned 841,045 shares of the company’s stock after purchasing an additional 220,555 shares during the period. Harbor Capital Advisors Inc.’s holdings in SI-BONE were worth $11,791,000 as of its most recent filing with the SEC.

Other large investors have also recently added to or reduced their stakes in the company. FMR LLC boosted its holdings in shares of SI-BONE by 103.6% during the 3rd quarter. FMR LLC now owns 2,354 shares of the company’s stock worth $33,000 after buying an additional 1,198 shares during the period. Canada Pension Plan Investment Board acquired a new stake in shares of SI-BONE during the 2nd quarter worth approximately $61,000. Walleye Capital LLC acquired a new position in shares of SI-BONE in the 3rd quarter valued at $144,000. Arizona State Retirement System boosted its position in shares of SI-BONE by 9.0% during the 2nd quarter. Arizona State Retirement System now owns 10,921 shares of the company’s stock valued at $141,000 after acquiring an additional 903 shares in the last quarter. Finally, Deerfield Management Company L.P. Series C bought a new stake in SI-BONE in the second quarter valued at about $151,000. Institutional investors own 98.11% of the company’s stock.

Insider Buying and Selling at SI-BONE

In other SI-BONE news, CEO Laura Francis sold 10,048 shares of SI-BONE stock in a transaction on Monday, November 18th. The shares were sold at an average price of $12.58, for a total value of $126,403.84. Following the sale, the chief executive officer now directly owns 482,875 shares in the company, valued at approximately $6,074,567.50. The trade was a 2.04 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Anshul Maheshwari sold 5,304 shares of the stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $13.91, for a total transaction of $73,778.64. Following the completion of the sale, the chief financial officer now owns 189,319 shares of the company’s stock, valued at approximately $2,633,427.29. This represents a 2.73 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 27,348 shares of company stock valued at $356,349. 3.90% of the stock is currently owned by company insiders.

SI-BONE Trading Down 4.7 %

Shares of SIBN traded down $0.67 on Friday, reaching $13.73. 99,031 shares of the company’s stock were exchanged, compared to its average volume of 227,964. SI-BONE, Inc. has a 12 month low of $11.70 and a 12 month high of $21.64. The stock has a market capitalization of $575.81 million, a P/E ratio of -14.92 and a beta of 1.16. The company has a current ratio of 8.25, a quick ratio of 7.22 and a debt-to-equity ratio of 0.22. The business has a 50 day moving average price of $13.67 and a two-hundred day moving average price of $14.17.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on SIBN. Truist Financial upped their price target on SI-BONE from $16.00 to $18.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Needham & Company LLC restated a “buy” rating and set a $19.00 target price on shares of SI-BONE in a report on Wednesday, November 20th. Six research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $23.00.

SI-BONE Profile

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.